Thursday, 15 October 2026European Markets
Via News Knowledge File

Federal Reserve

government agency80% conf.·synced Oct 15, 2026

U.S. central bank that may implement rate cuts as potential demand stimulus

59
sourced metrics
1550
relationships
20
stated objectives
8
Via News reports

Every fact below is drawn from Via News's knowledge graph and linked to the source document it came from. Nothing here is unsourced. How we source →

Key metrics · each point sourced

Unemployment Rate Forecast
4.4percent
Dec 31, 2026⚠ sources conflictsource
Core Pce Inflation Forecast
2.5percent
Dec 31, 2026⚠ sources conflictsource
Market Implied Probability Hold October 2026
63percent
Oct 14, 2026source
Market Implied Probability 25bp Hike October 2026
38percent
Oct 14, 2026source
Inflation Target
2percent
Sep 14, 2026source
Rate Hike Probability July
33percent
Jul 29, 2026source
Rate Hike Probability
31percent
Jul 8, 2026source
Rate Hike Probability Next Meeting
36percent
Jun 18, 2026source
Parameter Count
2percent
Jun 3, 2026source
Inflation Forecast
3.6percent
Jun 1, 2026source
Implied Rate Cut Probability Next Meeting
0percent
May 28, 2026source
Cash
6.7trillion_USD
May 24, 2026source
Debt
40trillion_USD_national_debt
May 19, 2026source
Gdp
3.75percent_upper_bound
May 17, 2026source
Employee Count
17chairs_historically
May 16, 2026source
Fomc Rate Cut Probability Next Meeting
3percent
Apr 30, 2026source
Fed Funds Rate
4percent
Apr 18, 2026source
Rate Cut Forecast
1cuts
Apr 17, 2026source

Stated objectives

Rate cuts in 2026

source
target: 1 by 2026-01-01 00:00:00stated

Normalization of target rate

source
target: 3.5% or 3.0% stated

Inflation rate target

source
target: 2.5% by 2026-01-01 00:00:00stated

Reduce federal funds rate by 250 basis points by end of 2026

source
target: 250 basis points decline by 2026-12-31 00:00:00stated

Purchase up to $40B per month in Treasury bills plus approximately $15B from MBS paydowns through reserve management program

source
target: 40B USD per month in bills stated

Cut interest rates two more times in 2025

source
target: 2 cuts by 2025-01-01 00:00:00stated

Bring interest rate range to 4%-4.25%

source
target: 4-4.25 percent by 2025-09-17 00:00:00stated

Reduce inflation to 2% target

source
target: 2 percent stated

Reduce Fed funds rate to 3.5-3.75% range by December 2025 meeting

source
target: 3.5-3.75% by 2025-12-31 00:00:00stated

Cut interest rates in December 2026

source
target: 25 basis points by 2026-12-01 00:00:00stated

Relationship graph · 1550 connections

regulates
575
Employs
377
subsidiary of
195
governs
65
Covered by
57
board member of
36
regulated by
23
located in
21

Via News coverage

This Knowledge File is assembled from Via News's source-traceable knowledge graph. Metrics, objectives and relationships are extracted from primary and credible secondary documents and refreshed on a schedule. Read our methodology →
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,377 source documents archived
Query this data → isubstrate.com